Advanced pharmacology

Advanced pharmacology

HH is a 68 yo M who has been admitted to the medical ward with community-acquired pneumonia for the past 3 days. His PMH is significant for COPD, HTN, hyperlipidemia, and diabetes. He remains on empiric antibiotics, which include ceftriaxone 1 g IV qday (day 3) and azithromycin 500 mg IV qday (day 3). Since admission, his clinical status has improved, with decreased oxygen requirements. He is not tolerating a diet at this time with complaints of nausea and vomiting. Advanced pharmacology

Ht: 5’8” Wt: 89 kg

Allergies: Penicillin (rash)

You are required to include at least three evidence based peer-reviewed journal articles or evidenced based guidelines which relates to this case to support your diagnostics and differentials diagnoses. Be sure to use correct APA 6th edition formatting. 2 pages

Case Study 2

A 46-year-old, 230lb woman with a family history of breast cancer. She is up to date on yearly mammograms. She has a history of HTN. She complains of hot flushing, night sweats, and genitourinary symptoms. She had felt well until 1 month ago and she presented to her gynecologist for her annual gyn examination and to discuss her symptoms. She has a history of ASCUS about 5 years ago on her pap, other than that, Pap smears have been normal. Home medications are Norvasc 10mg qd and HCTZ 25mg qd. Her BP today is 150/90. She has regular monthly menstrual cycles. Her LMP was 1 month ago. Advanced pharmacology

You are required to include at least three evidence based peer-reviewed journal articles or evidenced based guidelines which relates to this case to support your diagnostics and differentials diagnoses. Be sure to use correct APA 6th edition formatting. 2 pages

Women’s and Men’s Health/Infections and Hematologic Systems

As an advanced practice nurse, you will likely encounter many disorders associated with women’s and men’s health, such as hormone deficiencies, cancers, and other functional and structural abnormalities. Disorders such as these not only result in physiological consequences but also psychological consequences, such as embarrassment, guilt, or profound disappointment for patients. For these reasons, the provider-patient relationship must be carefully managed. During evaluations, patients must feel comfortable answering questions so that you, as a key health-care provider, will be able to diagnose and recommend appropriate treatment options. Advanced practice nurses must be able to educate patients on these disorders and help relieve associated stigmas and concerns. Advanced pharmacology

This week, you examine women’s and men’s health concerns as well as the types of drugs used to treat disorders that affect women’s and men’s health. You also explore how to treat aspects of these disorders on other health systems.

Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders

As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes? Advanced pharmacology

For this Discussion, you will be assigned 2 patient case studies and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.

Post a brief description of your patient’s health needs from each patient case study. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples. Advanced pharmacology

http://informahealthcare.com/tam ISSN: 1368-5538 (print), 1473-0790 (electronic)

Aging Male, 2015; 18(1): 5–15 ! 2015 The Author(s). Published by Taylor & Francis. DOI: 10.3109/13685538.2015.1004049

O R I G I N A L A R T I C L E

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men

Bruno Lunenfeld1, George Mskhalaya2, Michael Zitzmann3, Stefan Arver4, Svetlana Kalinchenko5, Yuliya Tishova5, and Abraham Morgentaler6

1Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, 2Department of Andrology, Center for Reproductive Medicine MAMA, Moscow, Advanced pharmacology

Russian Federation, 3

Centre for Reproductive Medicine and Andrology, University Clinics Muenster, Münster, Germany, 4

Centre for Andrology and

Sexual Medicine, Karolinska University Hospital and Karolinska Institutet Stockholm, Stockholm, Sweden, 5Clinical Endocrinology, Peoples’

Friendship University of Russia, Moscow, Russian Federation, and 6Men’s Health Boston, Harvard Medical School, Boston, MA, USA

ORDER A PLAGIARISM FREE PAPER NOW

Abstract

Hypogonadism or Testosterone Deficiency (TD) in adult men as defined by low levels of serum testosterone accompanied by characteristic symptoms and/or signs as detailed further on can be found in long-recognized clinical entities such as Klinefelter syndrome, Kallmann syndrome, pituitary or testicular disorders, as well as in men with idiopathic, metabolic or iatrogenic conditions that result in testosterone deficiency. These recommendations do not encompass the full range of pathologies leading to hypogonadism (testosterone deficiency), but instead focus on the clinical spectrum of hypogonadism related to metabolic and idiopathic disorders that contribute to the majority of cases that occur in adult men. Advanced pharmacology

Keywords

Hypogonadism, late-onset, men, testosterone deficiency, testosterone

History

Received 25 December 2014 Accepted 26 December 2014 Published online 6 February 2015

Introduction

The International Society for the Study of the Aging Male

(ISSAM) Hypogonadism panel consists of a multidisciplinary

group of experts, including urologists, endocrinologists,

andrologists and internists with various subspecialties. The

first recommendations were published in 2002 [1]. Due to the

need for ongoing re-evaluation of the information presented in

the recommendations they were revised in 2005 [2]. Clinical

guidelines present the best evidence available to the experts at

the time of writing, but as knowledge increased they were

again updated in 2009 [3]. Since then a great amount of new Advanced pharmacology

information accumulated which encouraged us in 2013 to

prepare a draft proposal for a further update [4]. This proposal

was presented at the VII ISSAM congress in Moscow. A final

form was presented at the ISSAM congress in Almaty,

Kazakhstan, and the final version was accepted by consensus.

It must however be remembered that recommendations can

never replace clinical expertise. Treatment decisions, selec-

tion of treatment protocols or choice of products for

individual patients must take into account patients’ personal

needs and wishes. The multidisciplinary group of experts

received no corporate funding or remuneration for preparing

these recommendations. Advanced pharmacology

Hypogonadism or Testosterone Deficiency (TD) in adult

men as defined by low levels of serum testosterone

accompanied by characteristic symptoms and/or signs as

detailed further on can be found in long-recognized clinical

entities such as Klinefelter syndrome, Kallmann syndrome,

pituitary or testicular disorders, as well as in men with

idiopathic, metabolic or iatrogenic conditions that result in

testosterone deficiency. These recommendations do not

encompass the full range of pathologies leading to hypogonad-

ism (testosterone deficiency), but instead focus on the clinical

spectrum of hypogonadism related to metabolic and idiopathic

disorders that contribute to the majority of cases that occur in

adult men Advanced pharmacology

Also check: Applying Quality Management in Healthcare

izmir eskort - eskort mersinizmir eskort - eskort mersin